Sarepta (SPRT): FDA Request for Dystrophin Data a 'Clear Indication Willing to Grant Accelerated Approval' - Baird

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/7/2026

1. MU
2. SPCX
3. APTX:CN
4. SPY
5. IQMX
6. MSTR
7. EROC
8. SEER
9. NVDA
10. RIVN

Go back to Sarepta (SPRT): FDA Request for Dystrophin Data a 'Clear Indication Willing to Grant Accelerated Approval' - Baird
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 19.18 -0.1 (0.52%)
Previous Close $19.28    52 Week High $63.73 
Open $19.21    52 Week Low $8.00 
Day High $19.63    P/E N/A 
Day Low $18.74    EPS $-5.69 
Volume 2,846,785